Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-24T16:29:29.188Z Has data issue: false hasContentIssue false
  • English
  • Français

Brain-Derived Neurotrophic Factor (Bdnf) and Gray Matter Volume in Bipolar Disorder

Published online by Cambridge University Press:  10 November 2016

S. Poletti ,
V. Aggio ,
T.A. Hoogenboezem ,
O. Ambrée ,
H. de Wit ,
A.J.M. Wijkhuijs ,
C. Locatelli ,
C. Colombo ,
V. Arolt  and
H.A. Drexhage
...Show all authors
S. Poletti*
Affiliation:
Department of clinical neurosciences, CERMAC (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), scientific institute, university Vita-Salute San Raffaele, Milan, Italy Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
V. Aggio
Affiliation:
Department of clinical neurosciences, CERMAC (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), scientific institute, university Vita-Salute San Raffaele, Milan, Italy
T.A. Hoogenboezem
Affiliation:
Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
O. Ambrée
Affiliation:
Department of psychiatry, university of Münster, Münster, Germany
H. de Wit
Affiliation:
Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
A.J.M. Wijkhuijs
Affiliation:
Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
C. Locatelli
Affiliation:
Department of clinical neurosciences, CERMAC (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), scientific institute, university Vita-Salute San Raffaele, Milan, Italy
C. Colombo
Affiliation:
Department of clinical neurosciences, CERMAC (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), scientific institute, university Vita-Salute San Raffaele, Milan, Italy
V. Arolt
Affiliation:
Department of psychiatry, university of Münster, Münster, Germany
H.A. Drexhage
Affiliation:
Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
F. Benedetti
Affiliation:
Department of clinical neurosciences, CERMAC (Centro di Eccellenza Risonanza Magnetica ad Alto Campo), scientific institute, university Vita-Salute San Raffaele, Milan, Italy Department of immunology, Erasmus university medical centre, Rotterdam, The Netherlands
*
* Corresponding author at: Istituto Scientifico Universitario Ospedale San Raffaele, Dipartimento di Neuroscienze Cliniche, San Raffaele Turro, Via Stamira d’Ancona 20, 20127 Milano, Italy. Tel.: +39 02 26433310; fax: +39 02 26433265. E-mail address:[email protected] (S. Poletti).
Get access

Abstract

Introduction

Bipolar Disorder (BD) is a severe psychiatric condition characterized by grey matter (GM) volumes reduction. Neurotrophic factors have been suggested to play a role in the neuroprogressive changes during the illness course. In particular peripheral brain-derived neurotrophic factor (BDNF) has been proposed as a potential biomarker related to disease activity and neuroprogression in BD. The aim of our study was to investigate if serum levels of BDNF are associated with GM volumes in BD patients and healthy controls (HC).

Methods

We studied 36 inpatients affected by a major depressive episode in course of BD type I and 17 HC. Analysis of variance was performed to investigate the effect of diagnosis on GM volumes in the whole brain. Threshold for significance was P < 0.05, Family Wise Error (FWE) corrected for multiple comparisons. All the analyses were controlled for the effect of nuisance covariates known to influence GM volumes, such as age, gender and lithium treatment.

Results

BD patients showed significantly higher serum BDNF levels compared with HC. Reduced GM volumes in BD patients compared to HC were observed in several brain areas, encompassing the caudate head, superior temporal gyrus, insula, fusiform gyrus, parahippocampal gyrus, and anterior cingulate cortex. The interaction analysis between BDNF levels and diagnosis showed a significant effect in the middle frontal gyrus. HC reported higher BDNF levels associated with higher GM volumes, whereas no association between BDNF and GM volumes was observed in BD.

Discussion

Our study seems to suggest that although the production of BDNF is increased in BD possibly to prevent and repair neural damage, its effects could be hampered by underlying neuroinflammatory processes interfering with the neurodevelopmental role of BDNF.

Keywords

BDNFGray matterNeuroinflammationBipolar disorder
Type
Original article
Information
European Psychiatry , Volume 40 , February 2017 , pp. 33 - 37
Copyright
Copyright © Elsevier Masson SAS 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Poletti, S.Vai, B.Smeraldi, E.Cavallaro, R.Colombo, C.Benedetti, F.Adverse childhood experiences influence the detrimental effect of bipolar disorder and schizophrenia on cortico-limbic grey matter volumes. J Affect Disord 2016; 189: 290–297CrossRefGoogle ScholarPubMed
Houenou, J.Frommberger, J.Carde, S.Glasbrenner, M.Diener, C.Leboyer, M.et al.Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses. J Affect Disord 2011; 132: 344–355CrossRefGoogle ScholarPubMed
Fusar-Poli, P.Howes, O.Bechdolf, A.Borgwardt, S.Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci 2012; 37: 170–184CrossRefGoogle ScholarPubMed
Machado-Vieira, R.Soeiro-De-Souza, M.G.Richards, E.M.Teixeira, A.L.Zarate, C.A. Jr.Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach. World J Biol Psychiatry 2013 2013–84CrossRefGoogle Scholar
Berk, M.Kapczinski, F.Andreazza, A.C.Dean, O.M.Giorlando, F.Maes, M.et al.Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804–817CrossRefGoogle ScholarPubMed
Berk, M.Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 2009; 12: 441–445CrossRefGoogle ScholarPubMed
Munkholm, K.Vinberg, M.Kessing, L.V.Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry 2015:216–28CrossRefGoogle Scholar
Matsuo, K.Walss-Bass, C.Nery, F.G.Nicoletti, M.A.Hatch, J.P.Frey, B.N.et al.Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 2009; 34: 1904–1913CrossRefGoogle ScholarPubMed
Chepenik, L.G.Fredericks, C.Papademetris, X.Spencer, L.Lacadie, C.Wang, F.et al.Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 2009; 34: 944–951CrossRefGoogle ScholarPubMed
Lang, U.E.Hellweg, R.Sander, T.Gallinat, J.The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 2009; 14: 120–122CrossRefGoogle ScholarPubMed
Schmohl, M.Schneiderhan-Marra, N.Baur, N.Hefner, K.Blum, M.Stein, G.M.et al.Characterization of immunologically active drugs in a novel organotypic co-culture model of the human gut and whole blood. Int Immunopharmacol 2012; 14: 722–728CrossRefGoogle Scholar
Ashburner, J.A fast diffeomorphic image registration algorithm. Neuroimage 2007; 38: 95–113CrossRefGoogle ScholarPubMed
Klein, A.Andersson, J.Ardekani, B.A.Ashburner, J.Avants, B.Chiang, M.C.et al.Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 2009; 46: 786–802CrossRefGoogle ScholarPubMed
Good, C.D.Johnsrude, I.S.Ashburner, J.Henson, R.N.Friston, K.J.Frackowiak, R.S.A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 2001; 14: 21–36CrossRefGoogle ScholarPubMed
Lancaster, J.L.Woldorff, M.G.Parsons, L.M.Liotti, M.Freitas, C.S.Rainey, L.et al.Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 2000; 10: 120–1313.0.CO;2-8>CrossRefGoogle ScholarPubMed
Schmidt, M.Brandwein, C.Luoni, A.Sandrini, P.Calzoni, T.Deuschle, M.et al.Morc1 knockout evokes a depression-like phenotype in mice. Behav Brain Res 2016; 296: 7–14CrossRefGoogle ScholarPubMed
Calabrese, F.van der Doelen, R.H.Guidotti, G.Racagni, G.Kozicz, T.Homberg, J.R.et al.Exposure to early life stress regulates Bdnf expression in SERT mutant rats in an anatomically selective fashion. J Neurochem 2015; 132: 146–154CrossRefGoogle Scholar
Angelucci, F.Brene, S.Mathe, A.A.BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry 2005; 10: 345–352CrossRefGoogle ScholarPubMed
Adler, C.M.Levine, A.D.DelBello, M.P.Strakowski, S.M.Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry 2005; 58: 151–157CrossRefGoogle ScholarPubMed
Patas, K.Penninx, B.W.Bus, B.A.Vogelzangs, N.Molendijk, M.L.Elzinga, B.M.et al.Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features. Brain Behav Immun 2014; 36: 71–79CrossRefGoogle ScholarPubMed
Neupane, S.P.Lien, L.Ueland, T.Mollnes, T.E.Aukrust, P.Bramness, J.G.Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders. Alcohol 2015; 49: 471–478CrossRefGoogle ScholarPubMed
Haarman, B.C.Riemersma-Van der Lek, R.F.de Groot, J.C.Ruhe, H.G.Klein, H.C.Zandstra, T.E.et al.Neuroinflammation in bipolar disorder – A [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav Immun 2014; 40: 219–225CrossRefGoogle ScholarPubMed
Pfaffenseller, B.Fries, G.R.Wollenhaupt-Aguiar, B.Colpo, G.D.Stertz, L.Panizzutti, B.et al.Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev Neurother 2013; 13: 827–842CrossRefGoogle ScholarPubMed
Martino, G.Furlan, R.Brambilla, E.Bergami, A.Ruffini, F.Gironi, M.et al.Cytokines and immunity in multiple sclerosis: the dual signal hypothesis. J Neuroimmunol 2000; 109: 3–9CrossRefGoogle ScholarPubMed
Fujimura, H.Altar, C.A.Chen, R.Nakamura, T.Nakahashi, T.Kambayashi, J.et al.Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002; 87: 728–734CrossRefGoogle ScholarPubMed
Watanabe, K.Hashimoto, E.Ukai, W.Ishii, T.Yoshinaga, T.Ono, T.et al.Effect of antidepressants on brain-derived neurotrophic factor (BDNF) release from platelets in the rats. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1450–1454CrossRefGoogle ScholarPubMed
Rybakowski, J.K.Factors associated with lithium efficacy in bipolar disorder. Harv Rev Psychiatry 2014; 22: 353–357CrossRefGoogle ScholarPubMed
Fukumoto, T.Morinobu, S.Okamoto, Y.Kagaya, A.Yamawaki, S.Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl) 2001; 158: 100–106CrossRefGoogle ScholarPubMed
Munkholm, K.Pedersen, B.K.Kessing, L.V.Vinberg, M.Elevated levels of plasma brain derived neurotrophic factor in rapid cycling bipolar disorder patients. Psychoneuroendocrinology 2014; 47: 199–211CrossRefGoogle ScholarPubMed
Barbosa, I.G.Rocha, N.P.Miranda, A.S.Huguet, R.B.Bauer, M.E.Reis, H.J.et al.Increased BDNF levels in long-term bipolar disorder patients. Rev Bras Psiquiatr 2013; 35: 67–69CrossRefGoogle ScholarPubMed
Huang, T.L.Hung, Y.Y.Lee, C.T.Chen, R.F.Serum protein levels of brain-derived neurotrophic factor and tropomyosin-related kinase B in bipolar disorder: effects of mood stabilizers. Neuropsychobiology 2012; 65: 65–69CrossRefGoogle ScholarPubMed
Tramontina, J.F.Andreazza, A.C.Kauer-Sant’anna, M.Stertz, L.Goi, J.Chiarani, F.et al.Brain-derived neurotrophic factor serum levels before and after treatment for acute mania. Neurosci Lett 2009; 452: 111–113CrossRefGoogle ScholarPubMed
Webster, M.J.Herman, M.M.Kleinman, J.E.Shannon Weickert, C.BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Expr Patterns 2006; 6: 941–951CrossRefGoogle ScholarPubMed
Pal, R.Singh, S.N.Chatterjee, A.Saha, M.Age-related changes in cardiovascular system, autonomic functions, and levels of BDNF of healthy active males: role of yogic practice. Age 36 2014 9683CrossRefGoogle ScholarPubMed
Erickson, K.I.Prakash, R.S.Voss, M.W.Chaddock, L.Heo, S.McLaren, M.et al.Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume. J Neurosci 2010; 30: 5368–5375CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.